Compare
Two to five companies, one table.
The same figures the grade is built from, lined up side by side. US and Indian listings can be compared together — with the caveat noted below.
Pick the companies
Side by side
| Measure | REGNRegeneron Pharmaceuticals, Inc. | MSFTMicrosoft Corporation |
|---|---|---|
| The grade | ||
| Grade | D+ | C |
| Quality score | 68.8 | 73.8 |
| Model stance | Hold | Hold |
| Risk band | High | High |
| Price and return | ||
| Price | $746.54 | $535.07 |
| Today | 0.94% | 2.38% |
| 1 month | -4.47% | 7.96% |
| 3 months | 13.91% | 39.27% |
| 6 months | 0.28% | 39.77% |
| Year to date | -3.46% | 13.85% |
| 1 year | 31.67% | 3.27% |
| Valuation | ||
| Market capitalisation | $76.86B | $3.97T |
| P/E | 18.46moderate | 29.81high |
| Forward P/E | 12.11low | 22.60moderate |
| PEG | 1.27fair | 1.74fair |
| Price to book | 2.36normal | 8.98well above book |
| Price to sales | 4.95high | 11.97high |
| Dividend yield | 0.50%modest | 0.73%modest |
| Risk | ||
| Beta | 0.15steadier than the market | 1.10market-like |
| Sharpe ratio | 0.30modest | 0.52modest |